November 06, 2025 4:43 pm
Ambiguous clutter of information needs to be replaced with clear visual imagery
May 02, 2025 8:53 am
The FDA's breakthrough devices program is intended to provide patients and health care providers with timely access to medical devices by speeding up development, assessment, and review,
January 29, 2025 8:21 pm
The issue was identified after a consumer alerted Lay’s to the presence of milk in the product, a major allergen that was not declared on the packaging.
July 22, 2023 7:10 am
These violations included carcinogens being present in the medicines, destroying or falsifying data, and using non-sterile manufacturing processes, the letter said.
February 04, 2023 7:46 am
The US agency said it was collaborating with the Centers for Disease Control and Prevention and state and local health departments to investigate a multistate outbreak involving a rare, extensively drug-resistant bacteria.
May 25, 2022 10:26 am
The regulator said it will be released to "individuals needing urgent, life-sustaining supplies" on a case-by-case basis.
July 12, 2021 11:22 am
The SpiroNose, made by the Dutch company Breathomix, is just one of many breath-based Covid-19 tests under development across the world. In May, Singapore’s health agency granted provisional authorization to two such tests, made by the domestic companies Breathonix and Silver Factory Technology.
July 10, 2021 1:28 pm
The drug, Aduhelm, was approved by the FDA on June 7 despite strong objection from its expert advisory panel, resulting in the resignation of three of its 11 members.
October 08, 2019 4:12 am
While share prices of Aurobindo fell 19.16%, Glenmark shares dropped by 9.30%, following observations on its Baddi facility.
February 06, 2015 1:46 am
Pfizer’s offer of $90 per share represents a premium of 39 per cent to Hospira stock’s close on Wednesday.
June 22, 2020 6:09 pm
The Indian Express-ICIJ investigation finds that at least 57 medical devices, many used in critical care, were being sold in India when the US Food and Drug Administration (FDA) clamped down on them for a range of faults over the last two years.




